In summary, this study demonstrates that low expression of calpain-2 is associated with poor survival in pancreatic cancer and low cytoplasmic calpastatin expression is associated with poor survival in cancers of the bile duct and ampulla. Here, CAPN2 is linked to familial pancreatic carcinoma.